Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Inhibition of development of experimental aortic abdominal aneurysm in rat model by atorvastatin through inhibition of macrophage migration.

Shiraya S, Miyake T, Aoki M, Yoshikazu F, Ohgi S, Nishimura M, Ogihara T, Morishita R.

Atherosclerosis. 2009 Jan;202(1):34-40. doi: 10.1016/j.atherosclerosis.2008.03.020. Epub 2008 Apr 6.

PMID:
18482727
2.

Focal histopathological progression of porcine experimental abdominal aortic aneurysm is mitigated by atorvastatin.

Houdek K, Moláček J, Třeška V, Křížková V, Eberlová L, Boudová L, Nedorost L, Tolinger P, Kočová J, Kobr J, Baxa J, Liška V, Witter K, Tonar Z.

Int Angiol. 2013 Jun;32(3):291-306.

PMID:
23711681
3.

Combination therapy with atorvastatin and amlodipine suppresses angiotensin II-induced aortic aneurysm formation.

Takahashi K, Matsumoto Y, Do e Z, Kanazawa M, Satoh K, Shimizu T, Sato A, Fukumoto Y, Shimokawa H.

PLoS One. 2013 Aug 13;8(8):e72558. doi: 10.1371/journal.pone.0072558. eCollection 2013.

4.

Statins exert differential effects on angiotensin II-induced atherosclerosis, but no benefit for abdominal aortic aneurysms.

Wang JA, Chen WA, Wang Y, Zhang S, Bi H, Hong B, Luo Y, Daugherty A, Xie X.

Atherosclerosis. 2011 Jul;217(1):90-6. doi: 10.1016/j.atherosclerosis.2011.03.005. Epub 2011 Mar 10.

PMID:
21481872
5.

Inhibition of endoplasmic reticulum stress signaling pathway: A new mechanism of statins to suppress the development of abdominal aortic aneurysm.

Li Y, Lu G, Sun D, Zuo H, Wang DW, Yan J.

PLoS One. 2017 Apr 3;12(4):e0174821. doi: 10.1371/journal.pone.0174821. eCollection 2017.

6.

Can statins suppress the development of abdominal aortic aneurysms? A review of the current evidence.

Saratzis A, Kitas GD, Saratzis N, Melas N.

Angiology. 2010 Feb;61(2):137-44. doi: 10.1177/0003319709335514. Epub 2009 Jul 21. Review.

PMID:
19625274
7.

Atorvastatin inhibits CXCR7 induction to reduce macrophage migration.

Ma W, Liu Y, Wang C, Zhang L, Crocker L, Shen J.

Biochem Pharmacol. 2014 May 1;89(1):99-108. doi: 10.1016/j.bcp.2014.02.014. Epub 2014 Feb 28.

PMID:
24582769
9.
10.

Combined effects of HMG-CoA-reductase inhibition and renin-angiotensin system blockade on experimental atherosclerosis.

Grothusen C, Bley S, Selle T, Luchtefeld M, Grote K, Tietge UJ, Drexler H, Schieffer B.

Atherosclerosis. 2005 Sep;182(1):57-69.

PMID:
16115475
11.

HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis.

Bustos C, Hernández-Presa MA, Ortego M, Tuñón J, Ortega L, Pérez F, Díaz C, Hernández G, Egido J.

J Am Coll Cardiol. 1998 Dec;32(7):2057-64.

12.

Resveratrol protects against atherosclerosis, but does not add to the antiatherogenic effect of atorvastatin, in APOE*3-Leiden.CETP mice.

Berbée JF, Wong MC, Wang Y, van der Hoorn JW, Khedoe PP, van Klinken JB, Mol IM, Hiemstra PS, Tsikas D, Romijn JA, Havekes LM, Princen HM, Rensen PC.

J Nutr Biochem. 2013 Aug;24(8):1423-30. doi: 10.1016/j.jnutbio.2012.11.009. Epub 2013 Jan 18.

PMID:
23337345
13.

The role of atorvastatin in regulating the immune response leading to vascular damage in a model of Kawasaki disease.

Blankier S, McCrindle BW, Ito S, Yeung RS.

Clin Exp Immunol. 2011 May;164(2):193-201. doi: 10.1111/j.1365-2249.2011.04331.x. Epub 2011 Mar 1.

16.

[Atorvastatin (Lipitor)].

Carpentier Y, Ducobu J, Sternon J.

Rev Med Brux. 1999 Oct;20(5):427-33. Review. French.

PMID:
10582478
17.

Suppression of experimental abdominal aortic aneurysms by systemic treatment with a hydroxamate-based matrix metalloproteinase inhibitor (RS 132908).

Moore G, Liao S, Curci JA, Starcher BC, Martin RL, Hendricks RT, Chen JJ, Thompson RW.

J Vasc Surg. 1999 Mar;29(3):522-32.

18.

Biphasic effects of atorvastatin on inflammation.

Garjani A, Andalib S, Ziaee M, Maleki-Dizaji N.

Pak J Pharm Sci. 2008 Apr;21(2):125-30.

PMID:
18390442
19.

Atorvastatin affects leukocyte gene expression in dyslipidemia patients: in vivo regulation of hemostasis, inflammation and apoptosis.

Wibaut-Berlaimont V, Randi AM, Mandryko V, Lunnon MW, Haskard DO, Naoumova RP.

J Thromb Haemost. 2005 Apr;3(4):677-85.

20.

Simvastatin suppresses experimental aortic aneurysm expansion.

Kalyanasundaram A, Elmore JR, Manazer JR, Golden A, Franklin DP, Galt SW, Zakhary EM, Carey DJ.

J Vasc Surg. 2006 Jan;43(1):117-24.

Supplemental Content

Support Center